FDA label
What is Prolensa used for?
Prolensa contains bromfenac. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “PROLENSA ®is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Prolensa?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Prolensa, solution/ drops
Indications and Usage, quoted from the label by Bausch & Lomb Incorporated (NDA203168). Cross-references to other label sections are left out.
PROLENSA ®is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
Source: DailyMed label, set id 4e072537-f73c-4a96-a65f-e2805ce112d8, version 19, effective May 5, 2026. NDC 24208-602, one of 1 listing for this product.
Questions
What is Prolensa used for?
The FDA label says: “PROLENSA ®is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.”
What drug class is Prolensa?
FDA lists bromfenac in the Nonsteroidal Anti-inflammatory Drug established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Prolensa
- Is Prolensa a controlled substance?Federal schedule
- Generic for ProlensaFDA Orange Book
- What is Bromfenac used for?FDA label uses
- Is Bromfenac a controlled substance?Federal schedule
- Generic for BromdayFDA Orange Book
- Generic for BromsiteFDA Orange Book
- Generic for XibromFDA Orange Book
- Nonsteroidal Anti-inflammatory Drugs listFDA drug class
- NDC 24208-602Prolensa NDC record